Clinical Trial Detail

NCT ID NCT03670069
Title Itacitinib in Treating Participants With Refractory Metastatic/Advanced Soft Tissue Sarcomas
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Fred Hutchinson Cancer Research Center
Indications

myxoid liposarcoma

cellular myxoid liposarcoma

sarcoma

synovial sarcoma

leiomyosarcoma

Therapies

Itacitinib

Age Groups: adult senior

No variant requirements are available.